Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-May-23 10:00 PM View:  | Luthringer Remy CEO Director | Minerva Neurosciences, Inc. (NERV) | 02-May-23 | Sale | 3,641 | $3.76 | $13,690.20 | (2%) 188.46K to 184.82K | |
| 02-May-23 10:00 PM View: | Luthringer Remy CEO Director | Minerva Neurosciences, Inc. (NERV) | 01-May-23 | Sale | 23,753 | $3.85 | $91,449.00 | (11%) 212.21K to 188.46K | |
| 02-May-23 10:00 PM View: | Ahlholm Frederick W SVP, CFO and Secretary | Minerva Neurosciences, Inc. (NERV) | 01-May-23 | Sale | 3,580 | $4.48 | $16,038.40 | (17%) 21.1K to 17.52K | |
| 02-May-23 10:00 PM View: | Race Geoff President | Minerva Neurosciences, Inc. (NERV) | 01-May-23 | Sale | 22,082 | $3.85 | $85,015.70 | (30%) 73.41K to 51.32K | |
| 02-May-23 10:00 PM View: | Race Geoff President | Minerva Neurosciences, Inc. (NERV) | 28-Apr-23 | Grant | 46,987 | -- | -- | 178% 26.42K to 73.41K | |
| 02-May-23 10:00 PM View: | Luthringer Remy CEO Director | Minerva Neurosciences, Inc. (NERV) | 28-Apr-23 | Grant | 88,077 | -- | -- | 71% 124.14K to 212.21K | |
| 02-May-23 10:00 PM View: | Ahlholm Frederick W SVP, CFO and Secretary | Minerva Neurosciences, Inc. (NERV) | 28-Apr-23 | Grant | 19,843 | -- | -- | 1581% 1.25K to 21.1K | |
| 03-Dec-21 5:37 PM View: | Kupfer David Director | Minerva Neurosciences, Inc. (NERV) | 01-Dec-21 | Sale | 55,635 | $0.88 | $48,958.80 | (23%) 247.12K to 191.49K | |
| 16-Dec-20 8:37 PM View: | Reilly Joseph H. SVP & Chief Operating Officer | Minerva Neurosciences, Inc. (NERV) | 16-Dec-20 | Market Option Sale | 3,228 | $2.64 | $8,521.92 | (9%) 34.98K to 31.75K | 7% |
| 16-Dec-20 8:29 PM View: | Ahlholm Frederick W SVP, Chief Accounting Officer | Minerva Neurosciences, Inc. (NERV) | 16-Dec-20 | Market Option Sale | 1,845 | $2.64 | $4,870.80 | (16%) 11.88K to 10.04K | 7% |
| 16-Dec-20 8:29 PM View: | Luthringer Remy CEO Director | Minerva Neurosciences, Inc. (NERV) | 16-Dec-20 | Market Option Sale | 1,300 | $2.64 | $3,432.00 | (< 1%) 994.39K to 993.09K | 7% |
| 16-Dec-20 8:31 PM View: | Race Geoff EVP, CFO & CBO | Minerva Neurosciences, Inc. (NERV) | 16-Dec-20 | Market Option Sale | 6,190 | $2.64 | $16,341.60 | (3%) 217.54K to 211.35K | 7% |
| 16-Dec-20 8:29 PM View: | Luthringer Remy CEO Director | Minerva Neurosciences, Inc. (NERV) | 14-Dec-20 | Option Exercise | 18,750 | -- | -- | 2% 975.64K to 994.39K | |
| 16-Dec-20 8:31 PM View: | Race Geoff EVP, CFO & CBO | Minerva Neurosciences, Inc. (NERV) | 14-Dec-20 | Option Exercise | 12,500 | -- | -- | 6% 205.04K to 217.54K | |
| 16-Dec-20 8:29 PM View: | Ahlholm Frederick W SVP, Chief Accounting Officer | Minerva Neurosciences, Inc. (NERV) | 14-Dec-20 | Option Exercise | 5,000 | -- | -- | 73% 6.88K to 11.88K | |
| 16-Dec-20 8:37 PM View: | Reilly Joseph H. SVP & Chief Operating Officer | Minerva Neurosciences, Inc. (NERV) | 14-Dec-20 | Option Exercise | 8,750 | -- | -- | 33% 26.23K to 34.98K | |
| 11-Sep-20 5:13 PM View: | van Heek G Jan Director | Minerva Neurosciences, Inc. (NERV) | 10-Sep-20 | Market Purchase | 7,000 | $2.97 | $20,790.00 | 53% 13.33K to 20.33K | (17%) |
| 27-May-20 4:43 PM View: | Ahlholm Frederick W SVP, Chief Accounting Officer | Minerva Neurosciences, Inc. (NERV) | 26-May-20 | Market Sale (Planned) | 8,339 | $15.00 | $125,085.00 | (55%) 15.22K to 6.88K | 84% |
| 17-Dec-19 4:46 PM View: | Luthringer Remy CEO Director | Minerva Neurosciences, Inc. (NERV) | 17-Dec-19 | Market Option Sale | 2,412 | $7.10 | $17,125.20 | (< 1%) 978.06K to 975.64K | 65% |
| 17-Dec-19 4:48 PM View: | Race Geoff EVP, CFO & CBO | Minerva Neurosciences, Inc. (NERV) | 17-Dec-19 | Market Option Sale | 5,826 | $7.10 | $41,364.60 | (3%) 210.87K to 205.04K | 65% |
| 17-Dec-19 4:45 PM View: | Ahlholm Frederick W SVP, Chief Accounting Officer | Minerva Neurosciences, Inc. (NERV) | 17-Dec-19 | Market Option Sale | 1,557 | $7.10 | $11,054.70 | (9%) 16.78K to 15.22K | 65% |
| 17-Dec-19 4:44 PM View: | Reilly Joseph H. SVP & Chief Operating Officer | Minerva Neurosciences, Inc. (NERV) | 17-Dec-19 | Market Option Sale | 2,724 | $7.10 | $19,340.40 | (9%) 28.95K to 26.23K | 65% |
| 17-Dec-19 4:48 PM View: | Race Geoff EVP, CFO & CBO | Minerva Neurosciences, Inc. (NERV) | 14-Dec-19 | Option Exercise | 12,500 | -- | -- | 6% 198.37K to 210.87K | |
| 17-Dec-19 4:45 PM View: | Ahlholm Frederick W SVP, Chief Accounting Officer | Minerva Neurosciences, Inc. (NERV) | 14-Dec-19 | Option Exercise | 5,000 | -- | -- | 42% 11.78K to 16.78K | |
| 17-Dec-19 4:44 PM View: | Reilly Joseph H. SVP & Chief Operating Officer | Minerva Neurosciences, Inc. (NERV) | 14-Dec-19 | Option Exercise | 8,750 | -- | -- | 43% 20.2K to 28.95K | |
| 17-Dec-19 4:46 PM View: | Luthringer Remy CEO Director | Minerva Neurosciences, Inc. (NERV) | 14-Dec-19 | Option Exercise | 18,750 | -- | -- | 2% 959.31K to 978.06K | |
| 13-Dec-19 4:07 PM View: | Russell Richard E. President | Minerva Neurosciences, Inc. (NERV) | 12-Dec-19 | Market Sale | 3,113 | $7.42 | $23,098.50 | (8%) 36.88K to 33.77K | 67% |
| 01-Jul-19 4:43 PM View: | Doyle William F Director | Minerva Neurosciences, Inc. (NERV) | 27-Jun-19 | Market Purchase | 3,500 | $5.50 | $19,250.00 | 15% 22.61K to 26.11K | (55%) |
| 27-Jun-19 4:26 PM View: | Kupfer David Director | Minerva Neurosciences, Inc. (NERV) | 26-Jun-19 | Market Purchase | 10,000 | $5.55 | $55,500.00 | 4% 237.12K to 247.12K | (56%) |
| 27-Jun-19 4:28 PM View: | Hasler Hans Peter Director | Minerva Neurosciences, Inc. (NERV) | 26-Jun-19 | Market Purchase | 10,000 | $5.60 | $56,000.00 | 100% 0 to 10.0K | (56%) |
| 27-Jun-19 4:28 PM View: | Hilleman Jeryl L Director | Minerva Neurosciences, Inc. (NERV) | 26-Jun-19 | Market Purchase | 1,000 | $5.25 | $5,250.00 | 100% 0 to 1.0K | (53%) |
| 27-Jun-19 4:30 PM View: | van Heek G Jan Director | Minerva Neurosciences, Inc. (NERV) | 26-Jun-19 | Market Purchase | 10,000 | $5.37 | $53,700.00 | 300% 3.33K to 13.33K | (54%) |
| 26-Jun-19 4:12 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 24-Jun-19 | Market Sale | 197,000 | $6.01 | $1,184,840.00 | (5%) 4.1M to 3.9M | 59% |
| 21-Jun-19 4:12 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 20-Jun-19 | Market Sale | 33,575 | $4.34 | $145,759.00 | (< 1%) 4.13M to 4.1M | 43% |
| 21-Jun-19 4:12 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 19-Jun-19 | Market Sale | 77,243 | $4.44 | $343,152.00 | (2%) 4.21M to 4.13M | 45% |
| 19-Jun-19 4:10 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 18-Jun-19 | Market Sale | 49,675 | $4.44 | $220,522.00 | (1%) 4.26M to 4.21M | 45% |
| 19-Jun-19 4:10 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 17-Jun-19 | Market Sale | 56,243 | $4.45 | $250,208.00 | (1%) 4.31M to 4.26M | 45% |
| 17-Jun-19 4:26 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 14-Jun-19 | Market Sale | 25,169 | $4.50 | $113,188.00 | (< 1%) 4.34M to 4.31M | 45% |
| 17-Jun-19 4:26 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 13-Jun-19 | Market Sale | 53,298 | $4.51 | $240,550.00 | (1%) 4.39M to 4.34M | 46% |
| 13-Jun-19 4:55 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 12-Jun-19 | Market Sale | 26,901 | $4.57 | $122,989.00 | (< 1%) 4.42M to 4.39M | 46% |
| 13-Jun-19 4:55 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 11-Jun-19 | Market Sale | 33,150 | $4.78 | $158,354.00 | (< 1%) 4.45M to 4.42M | 49% |
| 21-May-19 4:10 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 20-May-19 | Market Sale | 200 | $6.07 | $1,215.00 | (< 1%) 4.45M to 4.45M | 60% |
| 21-May-19 4:10 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 17-May-19 | Market Sale | 22,718 | $6.02 | $136,681.00 | (< 1%) 4.47M to 4.45M | 59% |
| 16-May-19 6:09 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 16-May-19 | Market Sale | 44,836 | $6.37 | $285,673.00 | (< 1%) 4.52M to 4.47M | 61% |
| 16-May-19 6:09 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 15-May-19 | Market Sale | 53,418 | $6.64 | $354,466.00 | (1%) 4.57M to 4.52M | 63% |
| 16-May-19 6:09 PM View: | Index Venture Associates II... 10% Owner | Minerva Neurosciences, Inc. (NERV) | 14-May-19 | Market Sale | 36,574 | $7.05 | $258,022.00 | (< 1%) 4.61M to 4.57M | 65% |
| 26-Dec-18 4:43 PM View: | Doyle William F Director | Minerva Neurosciences, Inc. (NERV) | 20-Dec-18 | Market Purchase | 2,000 | $6.50 | $13,000.00 | 10% 20.61K to 22.61K | (62%) |
| 18-Dec-18 4:29 PM View: | Ahlholm Frederick W SVP, Chief Accounting Officer | Minerva Neurosciences, Inc. (NERV) | 17-Dec-18 | Market Option Sale | 1,559 | $7.46 | $11,630.10 | (12%) 13.34K to 11.78K | 67% |
| 18-Dec-18 4:27 PM View: | Reilly Joseph H. SVP & Chief Operating Officer | Minerva Neurosciences, Inc. (NERV) | 17-Dec-18 | Market Option Sale | 2,728 | $7.46 | $20,350.90 | (12%) 22.93K to 20.2K | 67% |
| 18-Dec-18 4:28 PM View: | Luthringer Remy CEO Director | Minerva Neurosciences, Inc. (NERV) | 17-Dec-18 | Market Option Sale | 2,604 | $7.46 | $19,425.80 | (< 1%) 961.91K to 959.31K | 67% |
